SK hynix's Nasdaq Debut: I Sold Micron And Bought It

(RTTNews) – Dermata Therapeutics, Inc. (DRMA) announced financial results for the second quarter ended June 30, 2026, alongside a corporate update highlighting its transition into a commercial-stage skincare company. The San Diego-based firm is preparing to launch its first direct-to-consumer product, Tome Foundational Treatment, on August 25, 2026. Second quarter results showed a net loss…

Bloom Energy (BE -3.97%) and GE Vernova (GEV +0.05%) have become two of the biggest beneficiaries of the artificial intelligence (AI) infrastructure build-out. Both are helping solve the same problem: the insatiable demand for electricity for new AI data centers. But they approach that opportunity very differently. And if I had $5,000 to invest in…

MHADA Lottery Result 2026 Today: The much-awaited MHADA lottery result has gone live at 12 pm, offering an opportunity to Mumbai citizens to buy up to 2,640 houses. The Maharashtra Housing and Area Development Authority (MHADA) runs these lotteries in cities like Mumbai and Pune, offering homes that are generally lower in comparison to regular…

News Published: Saturday, July 25, 2026, 20:56 [IST] Chief Justice of India (CJI) Surya Kant has clarified that his controversial “cockroach” remark was not directed at students, young people or protesters, but at persons allegedly entering the legal profession with fake or unrecognised law degrees. The clarification comes after criticism on social media, where the…

Odeta Kushi (pictured top), deputy chief economist at First American, said the latest flare-up fits a pattern she and her colleagues had already accounted for. Even if there is some volatility day-to-day, the overall pattern seems to be for elevated rates. “I think you can see some zigzag, but my baseline expectation is more of…

The GLP-1 market may be one of the fastest-growing in the pharmaceutical industry right now. Many of the largest drugmakers are looking to capitalize on this and are developing promising GLP-1 candidates. The list includes Roche (RHHBY -1.75%), Regeneron Pharmaceuticals (REGN -0.31%), Amgen (AMGN -0.63%), and others. However, there are also smaller biotechs looking to…